Paolo Cavazza, 10% Owner at SCICLONE PHARMACEUTICALS INC (SCLN), bought 29,133 shares at $2.01 ($59K) on 2008-01-22, disclosed to the SEC on 2008-01-24.
Open-market purchase of $59k SCLN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.01 | 7,035 | $14K | 24.1% |
| 2 | $2.01 | 22,098 | $44K | 75.9% |
| Total | $2.01 avg | 29,133 | $59K | 100% |
| Filing → |
| SNGX | SELL | 2017-12-01 | $1.2M | — | Filing → |
| SCLN | SELL | 2012-05-02 | $33.2M | — | Filing → |
| RGRX.OB | BUY | 2011-01-07 | $600K | — | Filing → |